Breast Cancer: Targets and Therapy
Volume 13, 2021 - Issue
Open access
267
Views
2
CrossRef citations to date
0
Altmetric
Original Research
Triple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
Jesse Lopes da Silva1 Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, BrazilCorrespondence[email protected]
https://orcid.org/0000-0002-0790-9917
Fabiana Resende Rodrigues2 Pathology Department, Brazilian National Cancer Institute, Rio de Janeiro, Brazil
https://orcid.org/0000-0001-5062-1065
Guilherme Gomes de Mesquita2 Pathology Department, Brazilian National Cancer Institute, Rio de Janeiro, Brazil
, Priscila Valverde Fernandes2 Pathology Department, Brazilian National Cancer Institute, Rio de Janeiro, Brazil
, Luiz Claudio Santos Thuler1 Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil
https://orcid.org/0000-0003-2550-6537
Andreia Cristina de Melo1 Division of Clinical Research and Technological Development, Brazilian National Cancer Institute (INCA), Rio de Janeiro, Brazil
https://orcid.org/0000-0002-1201-4333
Pages 31-44
|
Published online: 11 Jan 2021
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.